Robotic Radical Cystectomy

Radical cystectomy is one of the most significant operations in urological cancer surgery. It combines the aim of cancer control with permanent changes to urinary function — and requires careful patient selection, sound operative judgement, and thorough preparation for what life afterwards will involve.

It is the standard treatment for muscle-invasive bladder cancer and selected cases of high-risk non-muscle-invasive disease. The decision to proceed sits within a broader assessment of staging, imaging, pathology, and fitness for treatment — and should involve multidisciplinary input. This is not just about removing the cancer safely. It is about helping each patient understand which reconstruction is appropriate, what recovery is likely to involve, and what life afterwards may realistically look like.

Robotic assistance is used for cystectomy at this practice. It can be helpful in pelvic dissection and lymph node surgery, where working in a confined space with precise visualisation matters. The key issues, however, remain patient selection, cancer control, and sound judgement about reconstruction. The platform supports those decisions; it does not replace them.

The urinary diversion — the decision about how urine will leave the body after the bladder is removed — is often the most consequential part of the pre-operative conversation. That decision requires time and honest information. A stomal therapy nurse is involved early in the process, and multidisciplinary input is coordinated where the staging or treatment complexity warrants it.

For a broader overview of bladder cancer — including how it is staged, when cystectomy is recommended versus other approaches, and what the pathway looks like — see the Bladder Cancer page.

When is radical cystectomy recommended?

Cystectomy is indicated when the bladder cancer has invaded the muscle wall of the bladder, or in selected cases where high-risk non-muscle-invasive cancer has not responded to other treatments or carries a high risk of progression.

The decision is multidisciplinary. In selected patients, bladder-preserving approaches — combining chemotherapy and radiation — are a genuine alternative to cystectomy and should be part of the discussion. Cystectomy offers definitive surgical removal and provides important pathological information; bladder preservation avoids the operation and its consequences but is not appropriate for everyone. Which pathway fits the cancer, the patient's health, and what matters most to them is the work of the consultation — not a conclusion that arrives before it.

Urinary diversion — the decision that changes daily life

After the bladder is removed, urine needs a new route out of the body. There are two main options. Not every patient is suitable for both — the choice is made on oncological, functional and practical grounds, and is discussed in detail before surgery.

Ileal conduit (urostomy)

A short segment of bowel is used to create a channel that brings urine to a small opening (stoma) on the abdominal wall. Urine drains continuously into a bag worn against the skin. This is a reliable and well-established approach. It does not require the patient to actively empty the diversion, and it carries a lower rate of long-term complications than a neobladder. For many patients — particularly those with certain medical conditions, prior radiation, or concerns about the complexity of a neobladder — this is the right choice.

Neobladder

A larger segment of bowel is fashioned into a reservoir that is connected to the urethra, allowing patients to pass urine in a more conventional way. It avoids an external bag. However, it requires learning a new way to urinate, often involves some degree of leakage — particularly at night — and is not suitable for everyone. Suitability depends on cancer location, urethral margin status, bowel health, and the patient's capacity to manage the demands of a neobladder long-term.

Neither option is clearly superior. The right choice depends on the individual — their cancer, their health, their lifestyle, and what they are prepared to manage day-to-day. This conversation takes time and happens well before the operation, not the night before.

The procedure

Careful pre-operative planning — including staging, assessment of fitness for major surgery, and agreement on the diversion type — happens before the operating theatre. The operation itself is performed under general anaesthesia.

The bladder is removed along with the prostate and seminal vesicles in men, or the uterus, ovaries and part of the vaginal wall in women, depending on the cancer extent and individual anatomy. Pelvic lymph nodes are removed at the same time as part of cancer staging and treatment.

The urinary diversion is then constructed. Depending on the type chosen, the bowel is used to create the conduit or neobladder and the appropriate connections are made. The operation typically takes four to six hours, sometimes longer depending on complexity.

This is major surgery. Hospital stay is typically five to ten days. Full recovery takes several weeks to months, and adjustment to the new urinary function — whichever diversion is chosen — takes longer still.

Recovery and adjustment

Recovery from cystectomy is more involved than recovery from most other urological operations. The combination of major abdominal surgery, bowel involvement, and the need to adapt to a new way of managing urine means that preparation, support, and realistic expectations matter enormously.

Before surgery, patients meet with a stomal therapy nurse — regardless of which diversion is planned — to discuss practical management and, if an ileal conduit is being considered, to mark the stoma site. This appointment is important and should not be skipped.

In the weeks after surgery, the focus is on bowel recovery, wound healing, and learning to manage the urinary diversion. For ileal conduit patients, this means learning stoma care. For neobladder patients, this means learning the new technique for emptying and managing leakage while control improves.

Return to normal activity is gradual. Most patients are mobile within a day or two of surgery, but full recovery — including return to work, driving, and resuming normal life — takes six to twelve weeks or longer depending on individual circumstances and how the adjustment to the diversion progresses.

Risks and considerations

Radical cystectomy carries significant risks that should be understood before proceeding. These include bleeding, infection, bowel-related complications (including ileus and anastomotic leak), urinary leakage, blood clots, and the general risks of major surgery under general anaesthesia.

Longer-term considerations include urinary diversion complications — such as stomal or conduit problems for ileal conduit patients, or leakage, difficulty emptying, and metabolic changes for neobladder patients — and the impact on sexual function, which is significant and should be discussed specifically in your consultation.

The pathology report after surgery guides further treatment decisions. Where there is lymph node involvement, positive margins, or other high-risk features, adjuvant chemotherapy or close surveillance may be recommended.

A note on how these decisions are made

Cystectomy requires more preparation than most operations — not just physically, but informationally. Patients who understand what they are agreeing to, what the diversion will mean in practice, and what recovery genuinely involves are better placed to get through it.

That preparation is a structured part of the care here, not something squeezed into a pre-admission appointment. If you have been diagnosed with bladder cancer and want to understand whether cystectomy is appropriate, which diversion option suits your situation, or what recovery would actually involve, contact the rooms to arrange a consultation.

For more on bladder cancer — including staging, when cystectomy is recommended, and bladder-preserving alternatives — see Bladder Cancer.

Clinical note: This page provides general information and is not a substitute for individual medical advice. Treatment decisions should be based on personalised assessment, staging and multidisciplinary discussion of options.

Last reviewed: April 2026